Path: ...!eternal-september.org!feeder3.eternal-september.org!news.eternal-september.org!raubtier-asyl.eternal-september.org!.POSTED!not-for-mail
From: Bonita Montero <Bonita.Montero@gmail.com>
Newsgroups: comp.lang.c,comp.lang.c++
Subject: Re: Can you please verify that the analysis of these C functions is
 correct?
Date: Mon, 17 Jun 2024 16:11:12 +0200
Organization: A noiseless patient Spider
Lines: 47
Message-ID: <v4pg5p$morv$1@raubtier-asyl.eternal-september.org>
References: <v4obkj$f9p5$2@dont-email.me>
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
Injection-Date: Mon, 17 Jun 2024 16:11:06 +0200 (CEST)
Injection-Info: raubtier-asyl.eternal-september.org; posting-host="567fea0737ace9203b0a3bd3650a3401";
	logging-data="746367"; mail-complaints-to="abuse@eternal-september.org";	posting-account="U2FsdGVkX18zyduDi5nP7uMoBrGjtRJqGJfjUGd/HSI="
User-Agent: Mozilla Thunderbird
Cancel-Lock: sha1:hH79ggmmICAGtj3myqtslV1oYV4=
In-Reply-To: <v4obkj$f9p5$2@dont-email.me>
Content-Language: de-DE
Bytes: 2332

Am 17.06.2024 um 05:47 schrieb olcott:
> To understand this analysis requires a sufficient knowledge of
> the C programming language and what an x86 emulator does.
> 
> typedef void (*ptr)();
> int H0(ptr P);
> 
> void Infinite_Loop()
> {
>    HERE: goto HERE;
> }
> 
> void Infinite_Recursion()
> {
>    Infinite_Recursion();
> }
> 
> void DDD()
> {
>    H0(DDD);
>    return;
> }
> 
> int main()
> {
>    H0(Infinite_Loop);
>    H0(Infinite_Recursion);
>    H0(DDD);
> }
> 
> Every C programmer that knows what an x86 emulator is knows that when H0
> emulates the machine language of Infinite_Loop, Infinite_Recursion, and
> DDD that it must abort these emulations so that itself can terminate
> normally.
> 
> When this is construed as non-halting criteria then simulating
> termination analyzer H0 is correct to reject these inputs as non-
> halting.
> 
> *My POD24 diagnosis is reducing the time I have left to work on this*
> Validation of POD24 as a robust early clinical end point of poor
> survival in FL from 5225 patients on 13 clinical trials
> https://pubmed.ncbi.nlm.nih.gov/34614146/
> 

Everything correct, no further questions allowed.